Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 221 across all filing types
Latest filing 2021-07-29 Interim / Quarterly Rep…
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management Discussion and Analysis For the Three and Six months Ended May 31, 2021 and 2020' and contains detailed discussion of financial performance, business divisions, strategic plans, and financial results for the interim periods ending May 31, 2021 and 2020. It references unaudited condensed interim financial statements and discusses financial metrics such as revenues, net loss, cash used in operations, and working capital. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content aligns with the typical Management Discussion and Analysis (MD&A) section that accompanies interim or quarterly financial reports. Therefore, the document fits the category of an Interim / Quarterly Report (IR).
2021-07-29 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements including statements of financial position, operations and comprehensive loss, changes in equity, and cash flows for the three and six months ended May 31, 2021 and 2020. It is explicitly labeled as "Condensed Interim Financial Statements" and is unaudited. The presence of interim financial data and the period covered (three and six months) indicate this is a quarterly or interim financial report. The document is lengthy (15,000 characters) and contains substantive financial data, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2021-07-29 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of Dr. Sagar Parikh, MD to the Specialty Clinics Advisory Board of NeonMind Biosciences Inc. It focuses on management and advisory board changes, describing Dr. Parikh's background and role. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no capital changes, or other report types. The content is clearly about a management/board appointment. Therefore, the document fits best under Board/Management Information (MANG). The document length is 8800 characters, which is sufficient for a detailed announcement but does not contain financial statements or other report content.
2021-07-28 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release from NeonMind Biosciences Inc. providing an update on their integrated drug development plan for their lead drug candidate NEO-001 targeting obesity. It discusses regulatory strategy, upcoming meetings with FDA and Health Canada, and anticipated clinical trial initiation. The content is focused on R&D progress and regulatory planning rather than financial results, management changes, or shareholder voting. The document is about a development plan update and does not contain financial statements or detailed financial data. It is not a report itself but an announcement of progress and plans. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to development and regulatory strategy updates relevant to the company's capital and financing outlook, or possibly Regulatory Filings (RNS) as a fallback. However, since it is a detailed update on drug development and regulatory strategy, CAP is more appropriate than RNS. The document length is 8079 characters, which is substantial and contains substantive information about the company's development plans, not just a brief announcement. Hence, the classification is CAP with high confidence.
2021-07-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the launch of new functional mushroom coffee products by NeonMind Biosciences Inc. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about product launch and business activities rather than a financial report, management discussion, or regulatory filing. There is no indication of it being an earnings release, annual report, or any other formal financial or regulatory document. Therefore, it fits best under the category of a general regulatory announcement or miscellaneous corporate news, which corresponds to Regulatory Filings (RNS).
2021-06-29 English
News release - English.pdf
Investor Presentation Classification · 85% confidence The document is a press release announcing that NeonMind Biosciences Inc. will present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference. It includes details about the presentation date, registration, company background, and contact information. There is no financial data, no detailed investor presentation content, no earnings or annual report information, and no regulatory filing or certification. The document is essentially an announcement of an upcoming investor presentation event rather than the presentation itself or a detailed report. Therefore, the most appropriate classification is Investor Presentation (IP). The document length is over 5,000 characters and contains substantive information about the event and company strategy, consistent with an investor presentation announcement.
2021-06-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.